GUEST EDITORIAL An Inflection Point for Retinal Therapy

PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.

Share

  • 1

    Retina: Rapid advancements in suprachoroidal drug delivery have marked a potential inflection point.

  • 2

    Uveitic Macular Edema: Noninfectious uveitic macular edema is a key indication for suprachoroidal injections.

  • 3

    Gene Therapy: Suprachoroidal injections are garnering interest for applications in gene therapy and current trials in diabetic retinopathy and exudative AMD.

  • 4

    Melanoma: Discussions include light-activated suprachoroidal therapy for the treatment of indeterminate lesions and small choroidal melanoma.

  • 5

    Retinal Physician: The latest edition aims to familiarize retinal physicians with suprachoroidal drug delivery.

Original Source(s)

GUEST EDITORIAL An Inflection Point for Retinal Therapy

PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.

  • by Mark R. Barakat, MD

  • August 1, 2022

  • 4 min

Related Content

Can Diabetic Eye Testing Be Simplified?

Three-test models matched nine-test battery in classifying disease stages

Retinal AI Predicts Neonatal Lung Disease

Retinal scans already performed in the NICU could flag infants at risk for serious lung disease before standard diagnosis

Understanding Protocol AO, the DRCR Retina Network’s Study of Home OCT

A conversation with Christina Y. Weng, MD, MBA